DOCUSATE SODIUM AND SENNA is a Oral Tablet, Film Coated in the Human Otc Drug category. It is labeled and distributed by Direct Rx. The primary component is Docusate Sodium; Sennosides.
| Product ID | 61919-518_c9375f96-4526-4f72-ad50-be271e274101 |
| NDC | 61919-518 |
| Product Type | Human Otc Drug |
| Proprietary Name | DOCUSATE SODIUM AND SENNA |
| Generic Name | Docusate Sodium And Senna |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2014-01-01 |
| Marketing Category | OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL |
| Application Number | part334 |
| Labeler Name | DIRECT RX |
| Substance Name | DOCUSATE SODIUM; SENNOSIDES |
| Active Ingredient Strength | 50 mg/1; mg/1 |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
| Marketing Start Date | 2014-01-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | OTC monograph not final |
| Application Number | part334 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2014-01-01 |
| Marketing Category | OTC monograph not final |
| Application Number | part334 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2014-01-01 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | OTC monograph not final |
| Application Number | part334 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2014-01-01 |
| Ingredient | Strength |
|---|---|
| DOCUSATE SODIUM | 50 mg/1 |
| SPL SET ID: | efce4137-f632-4fe7-84be-f678f20c38ae |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0536-0355 | Docusate Sodium and Senna | Docusate Sodium and Senna |
| 61919-518 | DOCUSATE SODIUM AND SENNA | DOCUSATE SODIUM AND SENNA |